Jim Simons Passage Bio, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Passage Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,392,846 shares of PASG stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,392,846

Previous 1,125,574 23.75%

Holding current value

$1.41 Million

Previous $889,000 9.56%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.64 - $1.0 $171,054 - $267,272	267,272 Added 23.75%	1,392,846 $974,000
Q2 2024 Aug 09, 2024	SELL	$0.79 - $1.58 $63,160 - $126,321	-79,950 Reduced 6.63%	1,125,574 $889,000
Q1 2024 May 13, 2024	SELL	$0.86 - $1.73 $15,331 - $30,840	-17,827 Reduced 1.46%	1,205,524 $1.63 Million
Q4 2023 Feb 13, 2024	BUY	$0.6 - $1.01 $137,371 - $231,241	228,952 Added 23.02%	1,223,351 $1.24 Million
Q3 2023 Nov 14, 2023	BUY	$0.66 - $1.01 $10,100 - $15,457	15,304 Added 1.56%	994,399 $654,000
Q2 2023 Aug 11, 2023	BUY	$0.82 - $1.19 $11,639 - $16,892	14,195 Added 1.47%	979,095 $922,000
Q1 2023 May 12, 2023	SELL	$0.96 - $1.88 $217,200 - $425,350	-226,250 Reduced 18.99%	964,900 $924,000
Q4 2022 Feb 13, 2023	SELL	$1.06 - $1.48 $74,465 - $103,970	-70,250 Reduced 5.57%	1,191,150 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$1.22 - $2.48 $287,669 - $584,771	235,795 Added 22.99%	1,261,400 $1.58 Million
Q2 2022 Aug 12, 2022	BUY	$1.63 - $3.46 $407,019 - $863,979	249,705 Added 32.18%	1,025,605 $2.42 Million
Q1 2022 May 13, 2022	BUY	$2.66 - $6.49 $798,798 - $1.95 Million	300,300 Added 63.14%	775,900 $2.41 Million
Q4 2021 Feb 11, 2022	BUY	$6.24 - $10.2 $2.14 Million - $3.49 Million	342,400 Added 257.06%	475,600 $3.02 Million
Q3 2021 Nov 12, 2021	BUY	$9.73 - $15.52 $670,397 - $1.07 Million	68,900 Added 107.15%	133,200 $1.33 Million
Q2 2021 Aug 13, 2021	BUY	$12.44 - $19.45 $799,892 - $1.25 Million	64,300 New	64,300 $851,000
Q4 2020 Feb 10, 2021	SELL	$14.28 - $29.73 $359,856 - $749,196	-25,200 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$12.39 - $26.15 $312,228 - $658,980	25,200 New	25,200 $330,000

Others Institutions Holding PASG

# of Institutions

Shares Held

38.7M

Call Options Held

7.7K

Put Options Held

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $55M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account